INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,458 | -22.5% | 7,320 | 0.0% | 0.05% | -23.5% |
| Q2 2023 | $298,510 | +9.4% | 7,320 | 0.0% | 0.07% | -1.4% |
| Q1 2023 | $272,816 | +13.0% | 7,320 | +5.8% | 0.07% | -12.7% |
| Q4 2022 | $241,439 | -37.6% | 6,920 | 0.0% | 0.08% | -39.2% |
| Q3 2022 | $387,000 | +8.1% | 6,920 | 0.0% | 0.13% | +12.1% |
| Q2 2022 | $358,000 | -12.9% | 6,920 | +22.3% | 0.12% | -4.1% |
| Q1 2022 | $411,000 | -38.6% | 5,660 | 0.0% | 0.12% | -37.3% |
| Q4 2021 | $669,000 | -11.9% | 5,660 | 0.0% | 0.19% | -22.2% |
| Q3 2021 | $759,000 | -17.1% | 5,660 | 0.0% | 0.25% | -18.7% |
| Q2 2021 | $916,000 | +101.8% | 5,660 | 0.0% | 0.30% | +69.4% |
| Q1 2021 | $454,000 | +48.9% | 5,660 | +1.1% | 0.18% | +20.8% |
| Q4 2020 | $305,000 | – | 5,601 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |